Skip to content

Drug interactions

Deflazacort + Ublituximab

Severity: Moderate

Deflazacort and Ublituximab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ublituximab depletes B cells and deflazacort suppresses immune function, so the combination may increase the risk of infection. Corticosteroids are often given as premedication for infusions, but prolonged use adds to immunosuppression.

What this interaction means in plain words

Deflazacort and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deflazacort belongs to Miscellaneous; Ublituximab belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Additive immunosuppression from B-cell depletion and glucocorticoid effects.

What to do

Monitor for infections and review the need for continued corticosteroid. Check vaccination status and screen for hepatitis B before ublituximab.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deflazacort and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deflazacort with Ublituximab?

MediHelp rates the interaction as moderate. Deflazacort and Ublituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ublituximab depletes B cells and deflazacort suppresses immune function, so the combination may increase the risk of infection. Corticosteroids are often given as premedication for infusions, but prolonged use adds to immunosuppression.

How serious is the interaction between Deflazacort and Ublituximab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infections and review the need for continued corticosteroid. Check vaccination status and screen for hepatitis B before ublituximab.

What other medicines interact with Deflazacort?

MediHelp also lists interactions of Deflazacort with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Deflazacort page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in